Literature DB >> 16847292

Age-related macular degeneration and risk for stroke.

Tien Yin Wong1, Ronald Klein, Cong Sun, Paul Mitchell, David J Couper, Hong Lai, Larry D Hubbard, A Richey Sharrett.   

Abstract

BACKGROUND: Age-related macular degeneration (AMD) affects 7 million persons 40 years of age and older in the United States. Risk factors for the disease are similar to those for stroke.
OBJECTIVE: To determine what relationship, if any, exists between AMD and incident clinical stroke.
DESIGN: Prospective cohort study.
SETTING: The population-based Atherosclerosis Risk in Communities Study, which was conducted in Minnesota, Maryland, Mississippi, and North Carolina. PATIENTS: 10 405 persons between 49 and 73 years of age who had no history of stroke or coronary heart disease. MEASUREMENTS: Participants had retinal photographs taken between 1993 and 1995. A standardized protocol was used to evaluate the photographs for the presence of drusen and other signs of AMD. Incident stroke events were identified and validated by reviewing case records.
RESULTS: There were 498 early-stage and 10 late-stage cases of AMD in the cohort (n = 508). Over a 10-year period, 241 persons had an incident stroke event. After adjusting for age, sex, ethnicity, and site, the authors found that persons with early-stage AMD had a higher cumulative incidence of stroke than those without the disease (4.08% vs. 2.14%). The presence of early-stage AMD was associated with a higher adjusted risk for stroke (hazard ratio, 1.87 [95% CI, 1.21 to 2.88]). Further adjustment for systolic blood pressure, diabetes, cigarette smoking, and use of antihypertensive medications did not substantially alter this association (hazard ratio, 1.85 [CI, 1.19 to 2.87]). The authors found that the association between early-stage AMD and stroke varied by study site and patient ethnicity. Multivariable-adjusted hazard ratios were 3.15 and 1.07 in samples of white patients in Minnesota and Maryland, respectively; 3.77 in a sample of African-American patients in Mississippi; and 0.33 in a sample of mostly white patients (91%) in North Carolina. No site included sufficient numbers of both African-American and white patients to determine whether ethnicity contributed to the observed differences by study site. LIMITATIONS: There were few cases of late-stage AMD, and the cohort assembly method prohibited full understanding of variation by ethnicity and site.
CONCLUSION: Middle-aged persons with signs of early-stage AMD have a higher risk for stroke independent of traditional stroke risk factors.

Entities:  

Mesh:

Year:  2006        PMID: 16847292     DOI: 10.7326/0003-4819-145-2-200607180-00007

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  36 in total

1.  Age-related macular degeneration and long-term risk of stroke subtypes.

Authors:  M Kamran Ikram; Paul Mitchell; Ronald Klein; A Rickey Sharrett; David J Couper; Tien Y Wong
Journal:  Stroke       Date:  2012-04-24       Impact factor: 7.914

2.  Treatment of exudative age-related macular degeneration: many factors to consider.

Authors:  Timothy W Olsen
Journal:  Am J Ophthalmol       Date:  2007-08       Impact factor: 5.258

3.  [Age-related macular degeneration and risk of stroke].

Authors:  V Biousse; M-G Bousser; A Gaudric
Journal:  J Fr Ophtalmol       Date:  2008-01       Impact factor: 0.818

4.  Low-dose aspirin and medical record-confirmed age-related macular degeneration in a randomized trial of women.

Authors:  William G Christen; Robert J Glynn; Emily Y Chew; Julie E Buring
Journal:  Ophthalmology       Date:  2009-10-07       Impact factor: 12.079

Review 5.  Do statins have a role in the prevention of age-related macular degeneration?

Authors:  Sean W Tsao; Donald S Fong
Journal:  Drugs Aging       Date:  2013-04       Impact factor: 3.923

6.  SAVE-AMD: Safety of VEGF Inhibitors in Age-Related Macular Degeneration.

Authors:  Frank Enseleit; Stephan Michels; Isabella Sudano; Marc Stahel; Sandrine Zweifel; Oliver Schlager; Matthias Becker; Stephan Winnik; Matthias Nägele; Andreas J Flammer; Michel Neidhart; Nicole Graf; Christian M Matter; Burkhardt Seifert; Thomas F Lüscher; Frank Ruschitzka
Journal:  Ophthalmologica       Date:  2017-09-02       Impact factor: 3.250

7.  Age-Related Macular Degeneration and Coronary Artery Disease in a VA Population.

Authors:  Joseph Thomas; Sohail Mohammad; Richard Charnigo; Judit Baffi; Ahmed Abdel-Latif; Khaled M Ziada
Journal:  South Med J       Date:  2015-08       Impact factor: 0.954

8.  Joint assessment of intended and unintended effects of medications: an example using vascular endothelial growth factor inhibitors for neovascular age-related macular degeneration.

Authors:  Adrian R Levy; Shelagh Szabo; Andrew Briggs; Andreas Pleil; Alison Davie; Gergana Zlateva; Jonathan Javitt
Journal:  J Ophthalmol       Date:  2010-02-16       Impact factor: 1.909

9.  Relationship between RPE and choriocapillaris in age-related macular degeneration.

Authors:  D Scott McLeod; Rhonda Grebe; Imran Bhutto; Carol Merges; Takayuki Baba; Gerard A Lutty
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-04-08       Impact factor: 4.799

10.  Role of statins in the development and progression of age-related macular degeneration.

Authors:  Brian L VanderBeek; David N Zacks; Nidhi Talwar; Bin Nan; Joshua D Stein
Journal:  Retina       Date:  2013-02       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.